SNMMI Elects Munir Ghesani, MD, FACNM, FACR, as President-Elect at 2021 Annual Meeting

June 14, 2021

Reston, VAMunir Ghesani, MD, FACNM, FACR, chief of nuclear medicine and molecular imaging at Mount Sinai Health Enterprise and associate professor of radiology at Mount Sinai Hospital in New York, NY, has been named as president-elect for the Society of Nuclear Medicine and Molecular Imaging (SNMMI). SNMMI introduced a new slate of officers during its 2021 Virtual Annual Meeting, held June 11-15.

As a staunch advocate of the critical role of nuclear medicine in healthcare delivery, Ghesani has set goals to streamline approval of nuclear medicine and molecular imaging technologies; advance and promote education, quality, value and safety; and foster availability and clinical utilization of nuclear medicine. Of particular interest to Ghesani are creating a clear Food and Drug Administration (FDA) approval process, developing quality measures for reporting and appropriate use criteria, and establishing a sustainable domestic isotope supply and ensuring uninterrupted international imports.

According to Ghesani, collaborations are key for to achieving these goals. “Throughout my various roles at SNMMI, I have seen the value of effective collaborations,” noted Ghesani. “By working together with physicians, technologists, scientists, government agencies and other national and international societies, we have made great progress in advancing the field of nuclear medicine and molecular imaging.”

Ghesani earned his medical degree from Gujarat University, NHL Medical College, in Ahmedabad, India, in 1984. He completed a diagnostic radiology residency in 1988 at the KM School of Postgraduate Medicine and Research, followed by a diagnostic ultrasound fellowship in 1989 at LG Hospital and KM School of Postgraduate Medicine and Research, also in Ahmedabad. In 1993, Ghesani completed an internal medicine residency at Jersey City Medical Center in New Jersey, and in 1996, a nuclear medicine residency and fellowship at St. Luke’s-Roosevelt Hospital Center in New York. He then went on to do radiology residency, also at St Luke’s-Roosevelt Hospital Center. He has held academic appointments at New York University School of Medicine, Icahn School of Medicine at Mount Sinai, and Columbia University.

Within SNMMI, Ghesani has been an active member of the society’s governance, with a strong focus on advocacy. He has served as chair of the SNMMI Government Relations Committee and the SNMMI/FDA Task Force and Advocacy Domain chair for the SNMMI Value Initiative.  He was a co-chair of the SNMMI Membership Task Force and a member of the SNMMI Board of Directors. Ghesani has also held multiple leadership positions in the Greater New York Chapter of SNMMI, most recently as president.

In the greater nuclear medicine community, Ghesani has served as chair and director of the American Board of Nuclear Medicine and as president of the American College of Nuclear Medicine. Earlier this year, he won the ACNM Personal Best Mentor of the Year award. He has published 88 peer-reviewed journal articles and a book, Nuclear Medicine: A Case-Based Approach. Ghesani is certified by the American Board of Radiology, the American Board of Nuclear Medicine and the American Board of Internal Medicine.

Other SNMMI officers elected for 2021-22 are Richard L. Wahl, MD, St, Louis, Missouri, as president and Helen Nadel, MD, FRCPC, Stanford, California, as vice president-elect. SNMMI Technologist Section officers for 2020-21 are Dusty York, MAEd, CNMT, PET, ARRT(N)(CT), Chattanooga, TN, as president and Krystle W. Glasgow, MIS, CNMT, NMTCB(CT), NMAA, FSNMMI-TS, Birmingham, Alabama, as president-elect.

# # #

About the Society of Nuclear Medicine and Molecular Imaging

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientific and medical organization dedicated to advancing nuclear medicine and molecular imaging—vital elements of precision medicine that allow diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes.

SNMMI’s members set the standard for molecular imaging and nuclear medicine practice by creating guidelines, sharing information through journals and meetings and leading advocacy on key issues that affect molecular imaging and therapy research and practice. For more information, visit www.snmmi.org.